SMAD7 and pancreatic neoplasm: miRNA-367 promotes the invasiveness and metastasis of human pancreatic cancer cells by directly targeting the 3-untranslated region (3-UTR) of SMAD7, downregulating its expression of Smad7, and enhancing the TGF-β/Smad signaling pathway[107].